Siena, Italy

Guido Antoni

This inventor holds 2 USPTO granted patents. Top assignee: Sclavo Spa. Active years: 1988-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 59(Granted Patents)


Location History:

  • Castelnuovo Berardenga, IT (1988)
  • Siena, IT (1993)

Company Filing History:


Years Active: 1988-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guido Antoni: Innovator in Immunology

Introduction

Guido Antoni is a notable inventor based in Siena, Italy. He has made significant contributions to the field of immunology, particularly through his innovative work on synthetic peptides. With a total of 2 patents, his research focuses on enhancing immune responses.

Latest Patents

Antoni's latest patents include a synthetic nonapeptide designed for use as an adjuvant. This specification relates to a synthetic peptide converted into a salt comprising one or more amine groups. It is capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens that have low immunogenicity. Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy. Another significant patent is for a synthetic peptide with human interleukin 1 activity. This peptide can be used as a stimulant of immune functions and can be defined by a general formula.

Career Highlights

Guido Antoni has established himself as a key figure in his field, working at Sclavo Spa, where he continues to innovate and develop new therapeutic solutions. His work has the potential to significantly impact immunotherapy and vaccine development.

Collaborations

Antoni has collaborated with notable colleagues, including Aldo Tagliabue and Diana Boraschi, contributing to a rich environment of research and development.

Conclusion

Guido Antoni's contributions to immunology through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in immune response therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…